Form 8-K - Current report:
SEC Accession No. 0001437749-24-030919
Filing Date
2024-10-09
Accepted
2024-10-09 08:00:12
Documents
14
Period of Report
2024-10-04
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20241007c_8k.htm   iXBRL 8-K 26041
  Complete submission text file 0001437749-24-030919.txt   177544

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20241004.xsd EX-101.SCH 3892
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20241004_def.xml EX-101.DEF 13827
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20241004_lab.xml EX-101.LAB 18219
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20241004_pre.xml EX-101.PRE 13859
16 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20241007c_8k_htm.xml XML 4892
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

EIN.: 593029743 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 241361518
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)